Dexmedetomidine-Propofol and Ketamine-Propofol During Upper Gastrointestinal System Sedation

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

February 20, 2020

Study Completion Date

March 13, 2020

Conditions
Anesthesia; Reaction
Interventions
DRUG

Dexmedetomidine

Group D received 1mg/kg dexmedetomidine+0.5mg/kg propofol intravenous (iv) bolus, 0.5 μg/kg/h dexmedetomidine+ 0.5 mg/kg/h propfol infusion. Group K received 0.125 mL/kg bolus, 0.125 mL/kg/h ketamine+ propofol = ketofol infusion (ketofol was prepared with 4 mg propofol+2 mg ketamine).

Trial Locations (1)

65000

Van Yuzuncu Yil University, Van

All Listed Sponsors
lead

Yuzuncu Yıl University

OTHER

NCT04399226 - Dexmedetomidine-Propofol and Ketamine-Propofol During Upper Gastrointestinal System Sedation | Biotech Hunter | Biotech Hunter